QA: Diamedica Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001401040_2026_Diamedica_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001401040, Diamedica Therapeutics Inc

  xvar xval
0 AssetsCurrent 60,629,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 145,000
3 remainder_Assets 597,000
4 LiabilitiesCurrent 5,132,000
5 LiabilitiesNoncurrent 128,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,863,296
9 ResearchAndDevelopmentExpense 43,605,210
10 remainder_Expenses 28,603
11 remainder_Revenues 0
12 remainder_NetIncome 1,589,115
13 remainder_ComprehensiveNetIncome 24,253
  yvar yval
0 Assets 61,371,000
1 Liabilities 5,260,000
2 Expenses 53,497,109
3 Revenues 0
4 StockholdersEquity 56,111,000
5 NetIncome -51,907,994
6 ComprehensiveNetIncome -51,895,868
7 BaseVar 60,870,738
8 EconomicCapitalRatiobeforeLimitedLiability 2.11
9 EconomicCapitalRatio 3.10

Edgar->Model Mapping

Feature Distribution

Change over Time